Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 337

1.

Compassion and Health Care: A Discussion With the Dalai Lama.

Snyderman R, Gyatso T the 14th Dalai Lama.

Acad Med. 2019 Aug;94(8):1068-1070. doi: 10.1097/ACM.0000000000002709.

PMID:
30870154
2.

Integration of Personalized Health Planning and Shared Medical Appointments for Patients with Type 2 Diabetes Mellitus.

Drake C, Meade C, Hull SK, Price A, Snyderman R.

South Med J. 2018 Nov;111(11):674-682. doi: 10.14423/SMJ.0000000000000892.

PMID:
30392002
3.

Health Care Reform in the United States.

Meade C, Drake C, Snyderman R.

JAMA. 2016 Nov 8;316(18):1923-1924. doi: 10.1001/jama.2016.15237. No abstract available.

PMID:
27825005
4.

Precision medicine: beyond genomics to targeted therapies.

Snyderman R, Spellmeyer D.

Per Med. 2016 Mar;13(2):97-100. doi: 10.2217/pme.15.48. Epub 2016 Feb 8. No abstract available.

PMID:
29749898
5.

Value of Personalized Medicine.

Snyderman R, Meade C, Drake C.

JAMA. 2016 Feb 9;315(6):613. doi: 10.1001/jama.2015.17136. No abstract available.

PMID:
26864420
6.

Personalized Health Planning in Primary Care Settings.

Simmons LA, Drake CD, Gaudet TW, Snyderman R.

Fed Pract. 2016 Jan;33(1):27-34.

7.

Personalized medicine 2014: has healthcare been transformed?

Snyderman R.

Per Med. 2014 Jun;11(4):365-368. doi: 10.2217/pme.14.22. No abstract available.

PMID:
29783483
8.

Patient engagement as a risk factor in personalized health care: a systematic review of the literature on chronic disease.

Simmons LA, Wolever RQ, Bechard EM, Snyderman R.

Genome Med. 2014 Feb 26;6(2):16. doi: 10.1186/gm533. eCollection 2014.

9.
10.

Personalized medicine is more than genomic medicine: confusion over terminology impedes progress towards personalized healthcare.

Simmons LA, Dinan MA, Robinson TJ, Snyderman R.

Per Med. 2012 Jan;9(1):85-91. doi: 10.2217/pme.11.86.

PMID:
29783292
11.

Personalized health care as a pathway for the adoption of genomic medicine.

Burnette R, Simmons LA, Snyderman R.

J Pers Med. 2012 Nov 13;2(4):232-40. doi: 10.3390/jpm2040232.

12.

Personalized health care: from theory to practice.

Snyderman R.

Biotechnol J. 2012 Aug;7(8):973-9. doi: 10.1002/biot.201100297. Epub 2011 Dec 16. Review.

PMID:
22180345
13.

Introduction of Robert J. Lefkowitz.

Snyderman R.

J Clin Invest. 2011 Oct;121(10):4192-200. doi: 10.1172/JCI60816. Epub 2011 Oct 3. No abstract available.

14.

Commentary: Personalized health planning and the Patient Protection and Affordable Care Act: an opportunity for academic medicine to lead health care reform.

Dinan MA, Simmons LA, Snyderman R.

Acad Med. 2010 Nov;85(11):1665-8. doi: 10.1097/ACM.0b013e3181f4ab3c.

PMID:
20844424
15.

Improving health by taking it personally.

Snyderman R, Dinan MA.

JAMA. 2010 Jan 27;303(4):363-4. doi: 10.1001/jama.2010.34. No abstract available.

PMID:
20103762
16.

Creating meaningful health care reform.

Snyderman R.

J Clin Invest. 2009 Oct;119(10):2855-6. No abstract available.

17.

More about prospective health care.

Snyderman R, Yoediono Z.

Acad Med. 2009 May;84(5):541; author reply 541. doi: 10.1097/ACM.0b013e31819f6e7e. No abstract available.

PMID:
19704179
18.

Perspective: Prospective health care and the role of academic medicine: lead, follow, or get out of the way.

Snyderman R, Yoediono Z.

Acad Med. 2008 Aug;83(8):707-14. doi: 10.1097/ACM.0b013e31817ec800.

PMID:
18667879
19.

Proposal for a new health record to support personalized, predictive, preventative and participatory medicine.

Yoediono Z, Snyderman R.

Per Med. 2008 Jan;5(1):47-54. doi: 10.2217/17410541.5.1.47.

PMID:
29783395
20.

Prospective health care: the second transformation of medicine.

Snyderman R, Langheier J.

Genome Biol. 2006;7(2):104. Epub 2006 Feb 27.

21.
22.

Prospective care: a personalized, preventative approach to medicine.

Snyderman R, Yoediono Z.

Pharmacogenomics. 2006 Jan;7(1):5-9. No abstract available.

23.

AAP Presidential Address: The AAP and the transformation of medicine.

Snyderman R.

J Clin Invest. 2004 Oct;114(8):1169-73. No abstract available.

24.

The clinical researcher--an "emerging" species.

Snyderman R.

JAMA. 2004 Feb 18;291(7):882-3. No abstract available.

PMID:
14970069
25.

Prospective medicine: the role for genomics in personalized health planning.

Langheier JM, Snyderman R.

Pharmacogenomics. 2004 Jan;5(1):1-8. Review. No abstract available.

26.

Prospective medicine: the next health care transformation.

Snyderman R, Williams RS.

Acad Med. 2003 Nov;78(11):1079-84.

PMID:
14604864
27.

The new prevention. Research on causes of disease must be applied to remaking our care system.

Snyderman R, Williams RS.

Mod Healthc. 2003 May 26;33(21):19. No abstract available.

PMID:
12800288
28.

Personalized health planning.

Williams RS, Willard HF, Snyderman R.

Science. 2003 Apr 25;300(5619):549. No abstract available.

29.

Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation.

Richardson RM, Marjoram RJ, Barak LS, Snyderman R.

J Immunol. 2003 Mar 15;170(6):2904-11.

30.

Interleukin-8-mediated heterologous receptor internalization provides resistance to HIV-1 infectivity. Role of signal strength and receptor desensitization.

Richardson RM, Tokunaga K, Marjoram R, Sata T, Snyderman R.

J Biol Chem. 2003 May 2;278(18):15867-73. Epub 2003 Feb 19.

31.

Integrative medicine and the search for the best practice of medicine.

Gaudet TW, Snyderman R.

Acad Med. 2002 Sep;77(9):861-3. No abstract available.

PMID:
12228074
32.

Phospholipase C-beta 2 interacts with mitogen-activated protein kinase kinase 3.

Barr AJ, Marjoram R, Xu J, Snyderman R.

Biochem Biophys Res Commun. 2002 Apr 26;293(1):647-52.

PMID:
12054652
33.

Gauging supply and demand: the challenging quest to predict the future physician workforce.

Snyderman R, Sheldon GF, Bischoff TA.

Health Aff (Millwood). 2002 Jan-Feb;21(1):167-8. No abstract available.

PMID:
11900072
34.

Integrative medicine: bringing medicine back to its roots.

Snyderman R, Weil AT.

Arch Intern Med. 2002 Feb 25;162(4):395-7. No abstract available.

PMID:
11863470
35.

Function and regulation of chemoattractant receptors.

Haribabu B, Richardson RM, Verghese MW, Barr AJ, Zhelev DV, Snyderman R.

Immunol Res. 2000;22(2-3):271-9. Review.

PMID:
11339362
36.

RGS4 inhibits platelet-activating factor receptor phosphorylation and cellular responses.

Richardson RM, Marjoram RJ, Barr AJ, Snyderman R.

Biochemistry. 2001 Mar 27;40(12):3583-8.

PMID:
11297424
37.

Does economic theory justify changing policy that works?

Muller RW, Sheldon GF, Snyderman R.

Health Aff (Millwood). 2001 Mar-Apr;20(2):153-5. No abstract available.

PMID:
11260937
38.

Clinical research.

Snyderman R.

Science. 2000 Mar 17;287(5460):1928. No abstract available.

PMID:
10755941
39.

Ralph Snyderman, MD. CAM and the role of the academic health center. Interview by Bonnie Horrigan.

Snyderman R.

Altern Ther Health Med. 2000 Sep;6(5):86-93. No abstract available.

PMID:
10979166
40.

Targeted disruption of the leukotriene B(4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis.

Haribabu B, Verghese MW, Steeber DA, Sellars DD, Bock CB, Snyderman R.

J Exp Med. 2000 Aug 7;192(3):433-8.

41.

Regulation of the human chemokine receptor CCR1. Cross-regulation by CXCR1 and CXCR2.

Richardson RM, Pridgen BC, Haribabu B, Snyderman R.

J Biol Chem. 2000 Mar 31;275(13):9201-8.

42.

Identification of a region at the N-terminus of phospholipase C-beta 3 that interacts with G protein beta gamma subunits.

Barr AJ, Ali H, Haribabu B, Snyderman R, Smrcka AV.

Biochemistry. 2000 Feb 22;39(7):1800-6.

PMID:
10677230
43.

Oversight mechanisms for clinical research.

Snyderman R, Holmes EW.

Science. 2000 Jan 28;287(5453):595-7. No abstract available.

PMID:
10691540
44.

Chemoattractant receptors activate distinct pathways for chemotaxis and secretion. Role of G-protein usage.

Haribabu B, Zhelev DV, Pridgen BC, Richardson RM, Ali H, Snyderman R.

J Biol Chem. 1999 Dec 24;274(52):37087-92.

45.

Academic medicine can transform health care through clinical research.

Snyderman R.

Acad Med. 1999 Nov;74(11):1224-5. No abstract available.

PMID:
10587685
46.

Patients, physicians, and clinical trials: the other side of the coins.

Abramson SB, Flexner C, Snyderman R, Dieterich DT, Korn D, Temple R, Sherwood L, Goldblatt D.

J Investig Med. 1999 Sep;47(8):343-57. No abstract available.

PMID:
10510587
47.

Far beyond informed consent. US research institutions keep close watch on OPRR's suspensions.

Russell-Einhorn M, Vaitukaitis J, Snyderman R, Rubenstein A, Abramson R, Hays M, Goodman L.

J Investig Med. 1999 Jul;47(6):259-66. No abstract available.

PMID:
10431479
48.

Chemoattractant receptor cross-desensitization.

Ali H, Richardson RM, Haribabu B, Snyderman R.

J Biol Chem. 1999 Mar 5;274(10):6027-30. Review. No abstract available.

49.

Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation.

Richardson RM, Pridgen BC, Haribabu B, Ali H, Snyderman R.

J Biol Chem. 1998 Sep 11;273(37):23830-6.

50.

Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization.

Grimm MC, Ben-Baruch A, Taub DD, Howard OM, Resau JH, Wang JM, Ali H, Richardson R, Snyderman R, Oppenheim JJ.

J Exp Med. 1998 Jul 20;188(2):317-25.

Supplemental Content

Loading ...
Support Center